SPARC

Official Title: SPARC - Screening for Lung Cancer with Platelets via an AI-enabled RNA-based Classifier

Conditions: Lung Cancer, Lung Nodule

Brief Summary: The purpose of this study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses lung cancer. Using retrospective platelet transcriptomic data from 522 patients with non-small cell lung cancer (NSCLC, the most common type of lung cancer), an approach that appears to accurately classify lung cancer has been developed.

The study will build upon these retrospective analyses to prospectively recruit patients with newly diagnosed lung cancer, obtain platelet RNA samples from whole blood, and perform validation analyses. This research will also test whether this approach accurately distinguishes benign from malignant lung nodules.

Intervention/Treatment: Diagnostic Test: Platelet RNA-based assay

Learn More: Additional details about this study are available on https://clinicaltrials.gov/study/NCT07460440

Questions or Interested in Participating? To learn more about participation at our site, please contact our study team:

(801) 584-5665 or submit an inquiry